Stock Market News
Stay updated with the latest stock market news and insights
Stay updated with the latest stock market news and insights
Stay updated with the latest stock market news and insights
Sen. John Boozman's latest trades include a palladium ETF, UnitedHealth stock, and other bets that might hint at his market outlook.
The aluminum giant beat revenue estimates but fell short on earnings, with production and shipment trends painting a mixed picture.
The robotic surgery leader posted strong earnings and procedure growth, but investors sent the stock lower in after-hours trading.
Netflix reported Q2 earnings that were a mixed bag — revenue slightly missed estimates, but earnings per share beat by a penny. The real story is the guidance and what it means for the stock.
Nike ($NKE) stock gains 4% despite market drops. Is the tech picture improving, or is this just a brief rebound? Find out here.
IREN Ltd shares are down sharply as investors grapple with an $800 million executive compensation package, a potential cloud competitor in Meta, and a broad tech selloff.
ManpowerGroup (MAN) beat Q2 estimates and issued strong Q3 guidance, sending shares up over 35% as short sellers scrambled to cover.
The FDA has approved Merck's Lipfendra, the first once-daily oral PCSK9 inhibitor, for adults with high LDL cholesterol. Phase 3 trials showed reductions of up to 60%.
Super Micro Computer (SMCI) shares fell over 7% Thursday as a broader computing hardware selloff raised concerns about AI infrastructure inventory and growth.
T1 Energy (TE) drops 13% amid a broad tech selloff and rotation into defensive sectors. Here's the technical and fundamental picture.
New 12-month data from Insmed's TPIP extension study shows sustained benefits in pulmonary arterial hypertension, supporting the ongoing Phase 3 trial.
IBM shares have taken a beating after earnings, but they're sitting at a key support level that has historically sparked a rebound. Here's what traders are watching.
IQSTEL shares surge after reporting preliminary first-half 2026 revenue of $207 million, up 59% year over year, with growth plans ahead.
CareDx shares jump after Medicare finalizes coverage for its transplant monitoring tests, covering kidney, heart, and lung patients.
BofA lifts BlackRock (BLK) target to $1,320, pointing to massive gains in tokenization, private markets, and Aperio's record inflows.